Bortezomib API

Business Type
Wholesaler
Country
India
Category
Price
Rs 300 /Gram (Get Latest Price)

Product Detail

Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. CAS No.:179324-69-7 Molecular Weight:384.24 Molecular Formula:C19H25BN4O4 Purity:>99%
Mr. Ashish Verma
Contact Us Contact Details

Similar Products

Biochemicals

About our Company

Business Type
Wholesaler
Established
1990
Employess
11 - 50 People
Annual Revenue
US$1 Million - US$2.5 Million
Main Markets
North America, Eastern Europe, East Asia, Africa, South America, Southern Europe, South Asia, Oceania, Central America, Western Europe, Middle East
Export Ratio
91% - 100%
Products
Biochemicals

Regional Suppliers

Biochemicals in India

Contact Us

Xpress Care Pharmaceuticals

Mr. Ashish Verma

6-2-15/M Hanuman Temple Main Road

Mumbai Marahashtra 400040 India

Send us a message